Medicines for Malaria Venture

Novartis building
Biotech

Racing resistance, Novartis plans pivotal malaria drug trial

The solid dispersion formulation is entering phase 3 on the strength of evidence it may kill drug-resistant forms of the parasite.
Nick Paul Taylor Nov 23, 2022 7:20am
Pauline Williams MD - head of global health RD at GSK

FDA AdComm backs GSK’s 1-shot malaria therapy

Jul 16, 2018 8:55am
Malaria Mosquito

PATH partners with SD Biosensor for malaria treatment diagnostic

Jun 21, 2018 2:06pm